scispace - formally typeset
Open AccessJournal ArticleDOI

Impact of COVID-19 on clinical trials and clinical research: A systematic review

Reads0
Chats0
TLDR
A systematic review of the literature aims to assess the impact of the coronavirus disease-19 pandemic on the conduction of clinical trials and research as mentioned in this paper, finding that most sites conducting clinical trials other than COVID-19 are experiencing a delay in timelines and a complete halt of operations in lieu of this pandemic, thus affecting clinical research outcomes.
Abstract
Background: The World Health Organization has reported more than 31,186,000 confirmed cases of coronavirus disease-19 (COVID-19), including 962,343 deaths, worldwide as on September 21, 2020. The current COVID-19 pandemic is affecting clinical research activities in most parts of the world. The focus on developing a vaccine for SARS-CoV-2 and the treatment of COVID-19 is, in fact, disrupting many upcoming and/or ongoing clinical trials on other diseases around the globe. On March 18, 2020, the United States Food and Drug Administration (FDA) issued an updated guideline for the conduct of clinical trials during the current health emergency situation. The potential challenges, such as social distancing and quarantines, result in study participants' inaccessibility and trial personnel for in-person scheduled study visits and/or follow-up. Due to the sudden onset and wide-spread impact of COVID-19, its influence on the management of clinical trials and research necessitates urgent attention. Therefore, our systematic review of the literature aims to assess the impact of the COVID-19 pandemic on the conduction of clinical trials and research. The search for the relevant articles for review included the keywords "COVID-19" AND "clinical trial" in PubMed, MEDLINE, Embase, Google scholar and Google electronic databases. Key findings include: delaying subject enrollment and operational gaps in most ongoing clinical trials, which in turn has a negative impact on trial programmes and data integrity. Globally, most sites conducting clinical trials other than COVID-19 are experiencing a delay in timelines and a complete halt of operations in lieu of this pandemic, thus affecting clinical research outcomes.

read more

Citations
More filters
Journal ArticleDOI

Survey Fatigue During the COVID-19 Pandemic: An Analysis of Neurosurgery Survey Response Rates

TL;DR: In this article, the authors analyzed the effect of the COVID-19 pandemic on neurosurgery surveys and their response rates, and suggested strategies for improving survey data collection, including population targeting, collaboration between research teams to minimize duplicate surveys, and communication with respondents to convey study importance.
Journal ArticleDOI

Uptake and effectiveness of a self-guided mobile app platform for college student mental health

TL;DR: In this paper , a mixed-methods study aims to examine the uptake and effectiveness of an implementation of IntelliCare for College Students, a self-guided app-based mental health platform, on two university campuses.
Journal ArticleDOI

Safety Assessment of Glucose-Lowering Drugs and Importance of Structured Education during Ramadan: A Systematic Review and Meta-Analysis

TL;DR: A systematic review and meta-analysis of the literature shows that structured education and counselling by healthcare professionals can be an effective tool in preventing complications associated with fasting during Ramadan in people with T2DM.
Journal ArticleDOI

How the COVID-19 pandemic is changing clinical trial conduct and driving innovation in bioanalysis.

TL;DR: The long-term effects of the turbulence caused by the pandemic have yet to be fully understood, but it should already be clear that the increased focus on participant needs and on the logistical challenges of current models are not likely to fade away quickly.
References
More filters
Journal ArticleDOI

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

TL;DR: Moher et al. as mentioned in this paper introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses, which is used in this paper.
Journal ArticleDOI

Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19).

TL;DR: This article highlights key requirements for telehealth uptake, including flexible funding arrangements, training and accrediting the health workforce, to become a routinely used part of the health system.
Journal ArticleDOI

A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment.

TL;DR: A Novel Coronavirus Emerging in China A novel coronavirus, designated as 2019-nCoV, emerged in Wuhan, China, at the end of 2019, although many details of the emergence of this virus remain unknown.
Journal ArticleDOI

COVID-19: what is next for public health?

TL;DR: The WHO–UNICEF–Lancet Commission presents a candid assessment of the threats children face and the sombre implications for their future, and emphasises the role of community engagement in promoting the health and development of the world’s children.
Related Papers (5)